TOP2A gene expression was correlated with advanced stages of the disease, higher Gleason scores, aneuploidy formation and poor survival in prostate cancer (Figure 1B-G; Supplementary Figure 1B-I). This evidence concerns the gene TOP2A and prostate cancer.